| Document Date: 2014-05-08 02:54:50
Open Document File Size: 1,42 MBShare Result on Facebook
City CGEN-XXXX / Gilbertsville / Oxford / / Company HY Ag / JR Podojil4 1Compugen Ltd. / IgG / Tregs 13 / / Country United Kingdom / Israel / / / Event Product Issues / Man-Made Disaster / Product Recall / / Facility Northwestern University / Institute of Technology / / IndustryTerm Prevention of diabetes / / MedicalCondition IBD / multiple sclerosis / disease / SCID / psoriasis / rheumatoid arthritis / MS / diabetes / inflammatory / autoimmune diseases / / MedicalTreatment Immunotherapies / / Organization CD28 / Central Intelligence Agency / B7 / Northwestern University / Chicago / Institute of Technology / / Person Induction / / / Position model / / Product IL-10 / Enbrel / Enbrel 4mg/kg / / Technology transplantation / /
SocialTag |
Induction of Immune Tolerance by CGEN-15001, a Novel Immunomodulatory Fc Fusion Protein of the B7 Family I Hecht1, I Vaknin1, A Oren1, A Toporik1, N Tarcic1, G Rotman1, E Neria1, A Keren2, A Gilhar2,K McNamee3, R William